JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
Goldman Sachs BDC
GSBD
$1.12B
| $1.18M | ﹤0.01% |
55,600
+45,500
| +450% | +$940K |
|
3577
Herc Holdings
HRI
$5.64B
| $1.18M | ﹤0.01% |
24,170
-8,737
| -27% | -$408K |
|
|
GRTS
3578
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $1.18M | ﹤0.01% |
131,921
+6,451
| +5% | +$53.8K |
|
3579
Franklin Covey
FC
$227M
| $1.18M | ﹤0.01% |
36,557
+25,519
| +231% | +$925K |
|
3580
Prothena Corp
PRTA
$466M
| $1.17M | ﹤0.01% |
74,127
-27,156
| -27% | -$291K |
|
3581
Central Garden & Pet Co
CENT
$2.78B
| $1.17M | ﹤0.01% |
47,086
-93,659
| -67% | -$2.23M |
|
3582
MarineMax
HZO
$1.15B
| $1.17M | ﹤0.01% |
70,133
-145,812
| -68% | -$2.38M |
|
3583
iShares US Digital Infrastructure and Real Estate ETF
IDGT
$547M
| $1.17M | ﹤0.01% |
21,130
+7,887
| +60% | +$421K |
|
|
RAVN
3584
DELISTED
Raven Industries Inc
RAVN
| $1.16M | ﹤0.01% |
33,760
-4,156
| -11% | -$142K |
|
3585
Protolabs
PRLB
$2.21B
| $1.16M | ﹤0.01% |
11,433
-784
| -6% | -$77.7K |
|
|
IVC
3586
DELISTED
Invacare Corporation
IVC
| $1.16M | ﹤0.01% |
128,671
-278,872
| -68% | -$2.34M |
|
3587
Pacira BioSciences
PCRX
$924M
| $1.16M | ﹤0.01% |
25,556
+2,606
| +11% | +$111K |
|
3588
Materion
MTRN
$5.88B
| $1.16M | ﹤0.01% |
19,437
+1,489
| +8% | +$88.1K |
|
3589
Flotek Industries
FTK
$1.25B
| $1.15M | ﹤0.01% |
96,138
+5,048
| +6% | +$58.3K |
|
|
CBPO
3590
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $1.15M | ﹤0.01% |
9,893
+2,779
| +39% | +$322K |
|
3591
Ameresco
AMRC
$1.47B
| $1.15M | ﹤0.01% |
65,612
+29,741
| +83% | +$468K |
|
|
FTV.PRA
3592
DELISTED
Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A
FTV.PRA
| $1.15M | ﹤0.01% |
1,179
-3,298
| -74% | -$3.07M |
|
|
ACRE
3593
Ares Commercial Real Estate
ACRE
$264M
| $1.15M | ﹤0.01% |
72,336
-37,348
| -34% | -$579K |
|
3594
Northeast Bank
NBN
$1.16B
| $1.14M | ﹤0.01% |
52,060
+9,686
| +23% | +$214K |
|
3595
Revolve Group
RVLV
$1.72B
| $1.14M | ﹤0.01% |
+62,294
| New | +$1.18M |
|
|
SPNE
3596
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $1.14M | ﹤0.01% |
94,943
+44,361
| +88% | +$541K |
|
3597
Sutro Biopharma
STRO
$353M
| $1.14M | ﹤0.01% |
10,342
+488
| +5% | +$50.3K |
|
3598
Nicolet Bankshares
NIC
$3.73B
| $1.13M | ﹤0.01% |
15,349
+10,698
| +230% | +$754K |
|
3599
NovaGold Resources
NG
$3.4B
| $1.13M | ﹤0.01% |
126,306
+15,749
| +14% | +$109K |
|
3600
Alaunos Therapeutics
TCRT
$4.86M
| $1.13M | ﹤0.01% |
1,597
+1,246
| +355% | +$857K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.